GSK strikes $2.2bn deal to resolve legal cases in US over heartburn treatment ZantacThe Guardian • 10/09/24
GSK Reports Sustained Efficacy of RSV Vaccine Amidst Competition from Pfizer and ModernaGuruFocus • 10/08/24
GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV SeasonsBusiness Wire • 10/08/24
Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply, Bloomberg News reportsReuters • 10/04/24